Medtech VC activity declined in 2022 and 2023 but showed signs of recovery in the first quarter of 2025. Recent notable investments include Neko Health and Neuralink. However, VC exits remain rare, with challenges from regulatory resistance impacting dealmaking conditions.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing